Drugs

Health Canada approved Pluvicto in August 2022, but patients have been waiting since then for provincial health plans to announce coverage.

Researchers have identified criteria to predict which patients will likely maintain disease control with less frequent dosing.

Imbalances caused by PCOS put women at risk for metabolic syndrome, but the condition continues to be misdiagnosed, says Ontario physician Dr. Ashley White.

International group of experts develops an evidence-based clinical practice guideline (algorithm) for using metformin to prevent/treat antipsychotic-induced weight gain.

Health Canada has reviewed evidence on the link between glucagon-like peptide-1 (GLP-1) receptor agonists and suicide, self-harm and suicidal/self-harm ideation.

The fee, which is being implemented to pharmacies but not to prescribers, places unnecessary financial burdens on pharmacies, according to the CPhA.

A review of new launches, new indications, new dosage forms and Health Canada advisories.

As use becomes more widespread, understanding cannabinoid interactions with medications is essential for pharmacists and other healthcare providers.